Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy: Cancer Sensitizing Agents for Chemotherapy, cartea 18
Lucia Morbidellien Limba Engleză Hardback – 28 ian 2022
In addition, the book discusses clinical applications in various types of cancer, such as colorectal, lung, breast, renal, genitourinary, skin and brain and circulating tumors. It is a valuable resource for cancer researchers, clinicians and members of the biomedical field who wants to be up-to-date on the most recent and promising developments in the field.
- Provides the most updated reviews on anti-angiogenic drugs as chemosensitizers by leaders in the field
- Encompasses summarized tables and schematic diagrams in each chapter to give a clear overview on recent findings in a didactic manner
- Brings not only relevant information of current research but also new ideas and suggestions for further investigations to help advance the field
Din seria Cancer Sensitizing Agents for Chemotherapy
- 24% Preț: 777.19 lei
- 20% Preț: 815.26 lei
- 28% Preț: 797.17 lei
- 9% Preț: 795.47 lei
- 9% Preț: 800.59 lei
- 27% Preț: 785.13 lei
- 24% Preț: 785.37 lei
- 21% Preț: 822.76 lei
- 9% Preț: 793.59 lei
- 22% Preț: 804.01 lei
- 24% Preț: 794.76 lei
- 20% Preț: 821.94 lei
- 20% Preț: 823.88 lei
- 20% Preț: 823.17 lei
- 29% Preț: 786.42 lei
- 23% Preț: 791.57 lei
- 25% Preț: 827.72 lei
- 23% Preț: 797.69 lei
- 23% Preț: 798.81 lei
- 24% Preț: 825.78 lei
Preț: 788.59 lei
Preț vechi: 1031.67 lei
-24% Nou
Puncte Express: 1183
Preț estimativ în valută:
150.92€ • 156.77$ • 125.36£
150.92€ • 156.77$ • 125.36£
Carte tipărită la comandă
Livrare economică 27 ianuarie-10 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323901901
ISBN-10: 0323901905
Pagini: 294
Ilustrații: 80 illustrations (50 in full color)
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Seria Cancer Sensitizing Agents for Chemotherapy
ISBN-10: 0323901905
Pagini: 294
Ilustrații: 80 illustrations (50 in full color)
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Seria Cancer Sensitizing Agents for Chemotherapy
Cuprins
1. General Introduction to the book2. Angiogenesis: definition and role, cellular and molecular mechanisms, redundancy of angiogenic modulators, receptors and converging signaling3. Anti-angiogenic drugs (monotherapies): General characteristics; molecular mechanisms; efficacy and side effects4. Anti-angiogenic drugs (combination therapies): molecular mechanisms; efficacy and side effects5. Clinical applications in various cancers; state of the art of the approved protocols, ongoing clinical trials, gaps6. Antiangiogenic drugs as chemosensitizer in colorectal cancer7. Antiangiogenic drugs as chemosensitizer in lung cancer8. Antiangiogenic drugs as chemosensitizer for upper GI cancer9. Antiangiogenic drugs as chemosensitizer in breast cancer10. Antiangiogenic drugs as chemosensitizer in renal and genitourinary cancer11. Antiangiogenic drugs as chemosensitizer in skin cancer12. Antiangiogenic drugs as chemosensitizer in brain tumors13. Antiangiogenic drugs as chemosensitizer in circulating tumors14. Antiangiogenic drugs and radiosensitization: state of the art on protocols and experimental studies15. Resistance to combination treatments: mechanisms of resistance to antiangiogenic drugs and cross-talk with tumor cell mechanisms of resistance16. Combination of antiangiogenic drugs with immunotherapies: efficacious synergism; side effects and limits17. Prognostic and diagnostic biomarkers for therapy choice and to monitor antiangiogenic drug efficacy and toxicities18. Antiangiogenic strategies: one target or multitarget inhibitors; synthetic compounds, gene therapy and natural products19. Synthesis and application of dual inhibitors: rationale for development and state of the art of the studies20. Metronomic therapy: mechanisms, advantages and approved protocols alone or in combination21. Personalized medicine with tumor angiogenesis as diagnostic marker and therapeutic target22. General Conclusions and future perspectives